Hepatocellular carcinoma in the adult Fontan patient

Michael R Conroy1, Tabitha G Moe1

  • 1Department of Cardiology,Mayo Clinic,Scottsdale,Arizona,United States of America.

Cardiology in the Young
|September 20, 2016
PubMed

Insights

Hepatocellular carcinoma is a rare complication in Fontan procedure patients. This case highlights the importance of monitoring liver health in adults with Fontan circulation.

Area of Science:

  • Cardiology
  • Hepatology
  • Oncology

Background:

  • The Fontan procedure is a palliative surgery for complex congenital heart disease.
  • Fontan-associated liver disease (FALD) can lead to cardiac cirrhosis.
  • Hepatocellular carcinoma (HCC) is a rare but serious complication of FALD.

Observation:

  • A 36-year-old woman with a history of Fontan procedure for tricuspid atresia presented with worsening heart failure.
  • Investigations revealed abnormal liver enzymes and hepatomegaly.
  • Liver biopsy confirmed hepatocellular carcinoma.

Findings:

  • Hepatocellular carcinoma was diagnosed in a patient with a history of Fontan procedure.
  • This case underscores the association between cardiac cirrhosis in Fontan patients and HCC development.
  • Early detection of liver abnormalities is crucial in this population.

Implications:

  • Increased surveillance for HCC may be warranted in adult Fontan survivors.
  • Understanding the long-term oncological risks in Fontan patients is critical.
  • Further research into the pathogenesis of HCC in Fontan-associated liver disease is needed.